基于胆碱能抗炎通路探索脓毒症治疗的研究进展

来源 :中华危重病急救医学 | 被引量 : 0次 | 上传用户:lpwxlwan
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
胆碱能抗炎通路(CAP)是经迷走神经传出、脾神经中继支配脾脏,由脾脏T细胞将肾上腺素能刺激转换为胆碱能信号作用于巨噬细胞等,发挥抗炎效应,保持机体炎症反应平衡的重要神经免疫调节机制。由于促炎与抗炎反应失衡在脓毒症病生理过程中的关键性作用,调节CAP活性成为目前脓毒症治疗研究的重要着眼点。基于对CAP的认识,目前迷走神经刺激、药物激动剂模拟胆碱能信号和针刺等被应用于脓毒症治疗的研究探索中。本文对近年来有关CAP机制、生物学效应及其在脓毒症治疗中应用的研究进行综述。“,”The cholinergic anti-inflammatory pathway (CAP) is an important neuroimmunomodulatory mechanism that innervates the spleen through vagus nerve efferent and splenic nerve relay, and acts on macrophages by transforming adrenergic stimulation into cholinergic signal by spleen T cells, which plays an anti-inflammatory effect, and maintains the balance of inflammatory response. Due to the critical role of the imbalance of pro-inflammatory and anti-inflammatory responses in the physiological process of sepsis, regulating the activity of the CAP has become an important focus in the treatments of sepsis. Based on the understanding of the CAP, vagus nerve stimulation, drug agonists mimicking cholinergic signals, and acupuncture are currently applied in the research and exploration of sepsis treatment. This article summarizes the recent progress and prospects of the CAP mechanism, biological effects, and application in sepsis treatment.
其他文献
目的 分析网织红细胞平均血红蛋白含量(CHr)检验诊断不同人群缺铁性贫血(IDA)的作用.方法 选取80例IDA患者作为实验组,另选取80例健康体检者作为对照组.所有患者及健康体检者
目的:探究重症胰腺炎患者胃肠道功能护理干预效果.方法:76例研究对象选取自我院消化科2018年1月-2019年7月收诊的重症胰腺炎患者.随机数字法划分为常规护理对照组(38例)和优